Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Barnes, Louis Tartaglia

Premium
Gene Logic has promoted Thomas Barnes to senior vice president of discovery, a position that will put him in charge of drug repositioning, the company said this week.
 
Barnes will take over the position from Louis Tartaglia, who is resigning from the job to become a partner in a venture capital firm.
 
Barnes formerly was co-founder of the drug repositioning initiative at Millennium Pharmaceuticals, which Gene Logic purchased from Millennium in 2004.
 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.